Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neuroimmunology

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JNEUROIM.2004.01.010PMID 15081258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome?

  2002cited by this paper
• Differential Expression of Neurotrophic Factors and Inflammatory Cytokines by Myelin Basic Protein‐Specific and Other Recruited T Cells Infiltrating the Central Nervous System during Experimental Autoimmune Encephalomyelitis

  2002cited by this paper
• Prior poliomyelitis-evidence of cytokine production in the central nervous system.

  2002cited by this paper
• Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells.

  2001cited by this paper
• Astrocyte-Targeted Expression of IL-12 Induces Active Cellular Immune Responses in the Central Nervous System and Modulates Experimental Allergic Encephalomyelitis1

  2000cited by this paper
• Autoimmune encephalomyelitis ameliorated by AMPA antagonists

  2000cited by this paper
• Neuroprotection by Encephalomyelitis: Rescue of Mechanically Injured Neurons and Neurotrophin Production by CNS-Infiltrating T and Natural Killer Cells

  2000cited by this paper
• An 8‐year longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio

  1998cited by this paper
• Post-polio muscle dysfunction 29th ENMC workshop 14-16 October 1994, Naarden, the Netherlands.

  1996cited by this paper
• Post‐Polio Syndrome Spinal Cord Pathology

  1995cited by this paper
• Post-polio syndrome spinal cord pathology. Case report with immunopathology.

  1995cited by this paper
• Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

  1995cited by this paper
• A Double‐Blind, Placebo‐Controlled Trial of High‐Dose Prednisone for the Treatment of Post‐Poliomyelitis Syndrome

  1995cited by this paper
• Neuropathogenic actions of cytokines assessed in transgenic mice

  1995cited by this paper
• Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

  1993cited by this paper
• Intrathecal immune response in patients with the post-polio syndrome.

  1992cited by this paper
• Intrathecal immune response in patients with the post-polio syndrome

  1991cited by this paper
• T-cell alterations in late postpoliomyelitis.

  1989cited by this paper
• Post-polio syndrome: clinical experience with 132 consecutive outpatients.

  1987cited by this paper
• Pathology of spinal cord in post-poliomyelitis muscular atrophy.

  1987cited by this paper
• Pathology of spinal cord in post-poliomyelitis muscular atrophy.

  1987cited by this paper

• A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and post-acute sequelae of COVID-19 Syndrome.

  2024cites this paper
• Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders.

  2022cites this paper
• High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.

  2020cites this paper
• Passive immunization

  2020cites this paper
• Post-polio Syndrome: More Than Just a Lower Motor Neuron Disease

  2019cites this paper
• Post-Polio Syndrome

  2019cites this paper
• Post‐polio syndrome and the late effects of poliomyelitis: Part 2. treatment, management, and prognosis

  2018cites this paper
• Post-Polio Syndrome

  2018cites this paper
• Postpolio syndrome and the late effects of poliomyelitis. Part 1. pathogenesis, biomechanical considerations, diagnosis, and investigations

  2018cites this paper
• Why a Paper on Anesthesia and Polio in 2016?

  2016cites this paper
• Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.

  2015cites this paper
• Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis

  2015influential citation
• Immunoglobulin treatment in post-polio syndrome: Identification of responders and non-responders.

  2015cites this paper
• Elevated plasma inflammatory mediators in post-polio syndrome: No association with long-term functional decline.

  2015influential citation
• POST-POLIO SYNDROME - ANALYSIS OF INFLAMMATION AND IMMUNE MODULATION

  2014influential citation
• Immunoglobulin g for the treatment of chronic pain: report of an expert workshop.

  2014cites this paper
• Normal serum levels of immune complexes in postpolio patients

  2014cites this paper
• Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients.

  2014cites this paper
• Case report: Effect of immunoglobulin on pain in Post-Polio Syndrome—Three case reports

  2013cites this paper
• POST-POLIO SYNDROME - PHYSIOTHERAPEUTIC ANALYSIS AND INTERVENTIONS

  2013cites this paper
• A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome.

  2013cites this paper
• The anti-inflammatory properties of intravenous immunoglobulin in a murine model of allergic airway disease ; effects on the development of regulatory T-cells

  2013cites this paper
• 7 – Passive immunization

  2013cites this paper
• Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.

  2012cites this paper
• Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up

  2012cites this paper
• IVIG treatment in post-polio patients: evaluation of responders

  2012cites this paper
• Platelets in Inflammation and Immune Modulations: Functions Beyond Hemostasis

  2012cites this paper
• Intravenous Immunoglobulin in the Treatment of Neurological Diseases

  2011cites this paper
• Update on current and emerging treatment options for post-polio syndrome

  2010cites this paper
• Chapter 18. Post-Polio Syndrome

  2010cites this paper
• Einsatz intravenöser Immunglobuline in der Neurologie

  2010cites this paper
• Management of postpolio syndrome.

  2010cites this paper
• Update on current and emerging treatment options for post-polio syndrome

  2010cites this paper
• Aspects of fatigue in post-polio

  2010cites this paper
• Proteomics in neurological disease

  2009cites this paper
• Functioning and ageing with late-onset sequelae of poliomyelitis

  2009cites this paper
• Post-Polio Syndrome

  2009cites this paper
• Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation.

  2009influential citation
• Post-Poliomyelitis Syndrome

  2008cites this paper
• Post‐Polio Syndrome

  2008cites this paper
• Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins

  2008cites this paper
• Elevated serum inflammatory markers in post-poliomyelitis syndrome.

  2008cites this paper
• EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

  2008cites this paper
• Drug Insight: the use of intravenous immunoglobulin in neurology—therapeutic considerations and practical issues

  2007cites this paper
• Einsatz intravenöser Immunglobuline in der Neurologie: Aktuelle Entwicklungen

  2007cites this paper
• Post‐polio syndrome patients treated with intravenous immunoglobulin: a double‐blinded randomized controlled pilot study

  2007cites this paper
• Postural control in persons with late effects of polio

  2006cites this paper
• EFNS guideline on diagnosis and management of post‐polio syndrome. Report of an EFNS task force

  2006cites this paper
• Effect of intravenous immunoglobulin in patients with post-polio syndrome -- an uncontrolled pilot study.

  2006influential citation
• Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects

  2006cites this paper
• Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain.

  2006cites this paper
• EFNS guideline on diagnosis and management of post-polio syndrome . Report of an EFNS task force

  2006cites this paper
• Gene expression profiling of the effects of intravenous immunoglobulin in human whole blood.

  2006cites this paper
• Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.

  2006cites this paper
• Who iis llikely tto rreport a a d diagnosis o of p post-p polio s syndrome?

  2006cites this paper